Roozbeh A. Ahmadi, MD
Pain Management · Lodi
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
Offices
1 location · Norcal Pain Treatment Center Corp · 9 clinicians in this group
Hospitals listed: Parkland Health and Hospital System · Ut Southwestern University Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ahmadi’s office at (209) 448-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Texas T8744Physician License · since 2022 · expires 2026-08-31Delinquent - Incomplete RegistrationNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Parkland Health & Hospital SystemDallas, TXAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Parkland Health and Hospital SystemPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.58 (1.24 to 1.92), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.72 (2.1 to 3.34) · 3,543 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.111, Oct 2024 – Sep 2025
- Ut of Texas Southwestern University Hospital - William P. Clements Jr.Dallas, TXAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of The University of Texas System, which runs 7 hospitalsHome of Harold C. Simmons Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 3.5 (2.54 to 4.46) · 4,552 cases, Jul 2022 – Jun 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 136.98 (103.42 to 170.53) · 314 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.416, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.582, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.258, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.466, Oct 2024 – Sep 2025
See every measure and the patient survey for Parkland Health & Hospital System
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.58 (1.24 to 1.92) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.72 (2.1 to 3.34) · 3,543 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.111 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.09 (0.11 to 2.07) · 839 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 207.46 (154.63 to 260.3) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 42 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 162 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.9 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 147 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 1,452 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.02 to 0.45) · 3,637 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,745 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.89 (2.71 to 7.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 157 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.97 to 3.95) · 775 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.4 (0 to 14.81) · 170 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.58 (0.9 to 8.27) · 170 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.63 (1.15 to 4.12) · 199 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.936 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.677 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.134 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.021 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.721 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 83 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 19.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -10.4 · 138 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 291 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.4 to 7.5) · 117 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.9 (7.2 to 13.3) · 117 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.7 to 17.9) · 216 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 72 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,989 patients answered, 7% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 60% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Ut of Texas Southwestern University Hospital - William P. Clements Jr.
Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 0 better, 7 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.5 (2.54 to 4.46) · 4,552 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 136.98 (103.42 to 170.53) · 314 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.416 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.582 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.258 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.466 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.65 to 2.02) · 4,279 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.13 (0.96 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.1 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.3 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7 · 566 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.1 · 628 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 319 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.4 · 5,756 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.07 to 0.4) · 14,917 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.12 to 0.45) · 16,518 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.98 to 5.69) · 5,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0.29 to 2.22) · 3,181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.48 (5.62 to 11.34) · 3,127 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.11 (4.25 to 7.97) · 3,175 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.43 to 2.99) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.89 (0.53 to 1.25) · 13,807 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 105 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.084 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.59 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 199 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.2 · 1,065 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 24.6 · 132 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 11.4 · 688 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 21.3 · 653 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 861 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.6 (3.7 to 5.6) · 1,345 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (9.8 to 12.9) · 1,345 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 115 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.8 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15.9 (13 to 19.5) · 3,124 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,588 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,378 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 83% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 72% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$45,728
Medicare paid this office $45,728 for 207 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 72 | $9,412 | $90 |
| Long return visit (40+ min) | 47 | $8,389 | $140 |
| New patient visit (45+ min) | 65 | $7,626 | $117 |
| New patient visit (60+ min) | 37 | $6,164 | $167 |
| Short return visit (20+ min) | 31 | $2,240 | $64 |
See all 11 services
| Return visit (30+ min) | 72 | $9,412 | $90 |
| Long return visit (40+ min) | 47 | $8,389 | $140 |
| New patient visit (45+ min) | 65 | $7,626 | $117 |
| New patient visit (60+ min) | 37 | $6,164 | $167 |
| Short return visit (20+ min) | 31 | $2,240 | $64 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $1,629 | $86 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 17 | $1,561 | $65 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 14 | $1,050 | $70 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $910 | $48 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $387 | $32 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $123 | $7 |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | – | 32 | 15 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | – | 21 | 12 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | – | – | 24 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | – | – | 19 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | – | – | 19 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
207 Original Medicare patients in 2024. Average age 73 · Under 65 13% · 85 and older 9% · Women 59% · Also on Medicaid 16% · Health risk score 1.62. Above the middle of the specialty; the typical interventional pain management clinician is at 1.37.
Conditions among them: High blood pressure 75% · Diabetes 33% · Coronary heart disease 30% · Depression 30% · Chronic kidney disease 28% · Cancer 19% · Heart failure 17% · COPD 17% · Atrial fibrillation 14% · Stroke 12% · Dementia 11%.
The office billed $325,718, Medicare allowed $62,139 and paid $45,728; for 534 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 207 | 534 | 73 | 1.62 | $325,718 | $45,728 |
| 2023 | 159 | 616 | 72 | 1.56 | $260,076 | $45,170 |
| 2022 | 26 | 46 | 73 | 1.84 | $22,058 | $4,943 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Long return visit (40+ min) | 60 | $13,400 | $131 |
| Return visit (30+ min) | 58 | $7,602 | $94 |
| New patient visit (60+ min) | 49 | $7,455 | $152 |
| New patient visit (45+ min) | 34 | $4,099 | $121 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 29 | $2,886 | $90 |
| Short return visit (20+ min) | 18 | $1,380 | $69 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 19 | $845 | $40 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 13 | $405 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $251 | $9 |
2022: 1 service
| New patient visit (60+ min) | 16 | $2,668 | $167 |
Drugs they prescribed that Part D paid
$5,295
Pharmacies billed $5,295 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 12% of their Part D prescriptions (38 of 313) in 2024. At or below the middle of the specialty; the typical interventional pain management clinician is at 49%.
311 generic and fewer than 11 brand-name prescriptions · $5,295 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Methocarbamol | 85 | $1,132 | $13 |
| Gabapentin | 63 | $819 | $13 |
| Diclofenac | 15 | $567 | $38 |
| Hydrocodone-Acetaminophen | 21 | $540 | $26 |
| Celecoxib | 15 | $344 | $23 |
See all 10 drugs
| Methocarbamol | 85 | $1,132 | $13 |
| Gabapentin | 63 | $819 | $13 |
| Diclofenac | 15 | $567 | $38 |
| Hydrocodone-Acetaminophen | 21 | $540 | $26 |
| Celecoxib | 15 | $344 | $23 |
| Tizanidine | 11 | $191 | $17 |
| Meloxicam | 23 | $145 | $6 |
| Duloxetine | 14 | $122 | $9 |
| Methylprednisolone | 14 | $100 | $7 |
| Tramadol | 15 | $67 | $4 |
Year by year
| 2024 | 313 | 141 | 12% (38) | None | $5,295 |
| 2023 | 223 | 86 | 9% (19) | None | $3,364 |
| 2022 | 13 | None | None | 0% | $301 |
| 2020 | 25 | 12 | None | 0% | $422 |
| 2019 | 36 | 14 | None | None | $1,713 |
| 2018 | 23 | None | None | None | $802 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Gabapentin | 42 | $672 | $16 |
| Methocarbamol | 32 | $514 | $16 |
| Celecoxib | 25 | $396 | $16 |
| Hydrocodone-Acetaminophen | 14 | $309 | $22 |
| Meloxicam | 33 | $148 | $4 |
Money from drug and device companies
$115 in 2025
| 2025 | 4 | 5 | None | $115 |
| 2024 | 2 | 4 | None | $188 |
| 2023 | 2 | 25 | None | $986 |
| 2022 | 1 | 1 | None | $43 |
| 2021 | 1 | 1 | None | $119 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tonix Medicines | Tonmya | $53 | 2 payments
|
| Merz Pharmaceuticals | Xeomin | $28 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $18 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $16 | 1 payment
|
See all 5 published payments
| Tonix Medicines | Meals · 2025-12-03 | Tonmya | $20 |
| Tonix Medicines | Meals · 2025-11-12 | Tonmya | $32 |
| Merz Pharmaceuticals | Meals · 2025-09-24 | Xeomin | $28 |
| Vertex Pharmaceuticals | Meals · 2025-07-30 | Journavx | $16 |
| Collegium Pharmaceutical | Meals · 2025-07-28 | Belbuca | $18 |
See earlier years (2024, 2023, 2022, 2021)
2024: $188
| Boston Scientific | Wavewriter Alpha Prime 16 | $167 | 3 payments
|
| Medtronic | Intellis Adaptivestim | $21 | 1 payment
|
2023: $986
| Medtronic | Intellis Adaptivestim | $900 | 23 payments
|
| Stryker | Optablate | $86 | 2 payments
|
2022: $43
| SPR Therapeutics | Sprint Pns System | $43 | 1 payment
|
2021: $119
| Boston Scientific | Wavewriter Alpha | $119 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1134657943
- Licence
- TX T8744Texas T8744: Delinquent - Incomplete Registration
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208VP0014X (208VP0014X); Federal specialty code 208100000X (208100000X); Federal specialty code 2081P2900X (2081P2900X)
- Mailing address
- Po Box 1462, Hughson, CA, 95326
- NPI first listed
- 2017-05-24
- NPI last updated
- 2025-06-17
- NPI record certified
- 2025-06-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5161 Harry Hines Csw1.104, Dallas, TX, 75390